Last update:

Weight management news

Young women lead sevenfold rise in adult brain pressure disorder rates in Victoria

Idiopathic intracranial hypertension, or IIH, is defined by raised pressure around the brain with no structural cause and normal spinal fluid composition.

Semaglutide may improve eating disorder symptoms and body image in adults seeking obesity treatment

Adults receiving semaglutide for obesity treatment experienced greater improvements in several measures of disordered eating, eating disorder symptoms and body image concerns compared with participants receiving placebo, ...

Why don't GLP‑1 obesity drugs work for everyone?

Medications like Ozempic and Wegovy, which contain semaglutide—a GLP‑1 receptor agonist that helps regulate blood sugar, appetite and body weight—have become household names and important pillars in obesity management for ...

Weekly weight-loss injection combo shows promise

Two lower doses of CagriSema, a weekly injection combining two appetite-reducing medicines, cagrilintide and semaglutide, led to substantial weight loss in adults with obesity or with overweight and a weight-related health ...

RNA switch lets drugs control gene therapy protein production

Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable ...

China approves first oral GLP-1 weight-loss pill

China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.

Night owls who eat late may face higher health risks

A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health and metabolic disease, offering new insights into why some individuals with obesity may face a risk of inflammation ...